Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $35.36M.
ENTERPRISE VALUE (EV)
$35.36M
Rani Therapeutics Holdings, Inc.
Market Cap
$51.24M
Enterprise Value (EV)
$35.36M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | $51.24M | $35.36M |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | $46.85M |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | $32.47M |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.54M | N/A |
| biote Corp. (BTMD)vs › | $51.61M | $169.08M |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $51.91M | $51.90M |
| Celularity Inc. (CELU)vs › | $50.80M | $110.74M |
| Clene Inc. (CLNN)vs › | $50.54M | $63.21M |
| Apollomics, Inc. (APLM)vs › | $50.38M | $47.74M |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | $42.98M |
Market Cap
$51.24M
Total Debt
$2.73M
Cash
$18.62M
Enterprise Value
$35.36M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
